Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Gupta

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Experimental Parasitology|June 21, 2025
Evaluation of β-caryophyllene(1-3) as a potential anti-tick molecule for controlling tick infestations on animalsGajanan M Chigure, Anil Kumar Sharma, K G Ajithkumar, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 16, 2021
Phone calls for improving blood pressure control among hypertensive patients attending private medical practitioners in India: Findings from Mumbai hypertension projectMandar Kannure, Asha Hegde, Anupam Khungar-Pathni, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
cGAS-STING dependent type I IFN protects against <i>Leptospira interrogans</i> renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
Journal of Medicinal Chemistry|February 21, 2018
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
European Journal of Medicinal Chemistry|October 8, 2013
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agentsVadiraj S Gopinath, Jakir Pinjari, Ravindra T Dere, et al.
Plos Pathogens|January 7, 2026
cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
European Journal of Pharmacology|March 5, 2011
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonistSuman Gupta, Shivani Malhotra, Sandeep Sinha, et al.
The Journal of Clinical Investigation|September 10, 2024
Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumoniaMarilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A Bora, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Experimental Parasitology|June 21, 2025
Evaluation of β-caryophyllene(1-3) as a potential anti-tick molecule for controlling tick infestations on animalsGajanan M Chigure, Anil Kumar Sharma, K G Ajithkumar, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 16, 2021
Phone calls for improving blood pressure control among hypertensive patients attending private medical practitioners in India: Findings from Mumbai hypertension projectMandar Kannure, Asha Hegde, Anupam Khungar-Pathni, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
cGAS-STING dependent type I IFN protects against <i>Leptospira interrogans</i> renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
Journal of Medicinal Chemistry|February 21, 2018
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
European Journal of Medicinal Chemistry|October 8, 2013
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agentsVadiraj S Gopinath, Jakir Pinjari, Ravindra T Dere, et al.
Plos Pathogens|January 7, 2026
cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
European Journal of Pharmacology|March 5, 2011
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonistSuman Gupta, Shivani Malhotra, Sandeep Sinha, et al.
The Journal of Clinical Investigation|September 10, 2024
Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumoniaMarilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A Bora, et al.
Pageof 14